Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Chui, Julia Wenger, S. Cohen, E. Naumova (2011)
Visual Analytics for Epidemiologists: Understanding the Interactions Between Age, Time, and Disease with Multi-Panel GraphsPLoS ONE, 6
A. Taegtmeyer, G. Kullak-Ublick, N. Widmer, Volkmar Falk, Alexander Jetter (2012)
Clinical Usefulness of Electronic Drug-Drug Interaction Checking in the Care of Cardiovascular Surgery InpatientsCardiology, 123
Erika Abramson, R. Kaushal (2012)
Computerized provider order entry and patient safety.Pediatric clinics of North America, 59 6
James Thomas, Kristin Cook (2006)
A Visual Analytics AgendaIEEE computer graphics and applications, 26 1
M. Harper, C. Longhurst, Troy McGuire, R. Tarrago, Bimal Desai, A. Patterson (2014)
Core Drug-Drug Interaction Alerts for Inclusion in Pediatric Electronic Health Records With Computerized Prescriber Order EntryJournal of Patient Safety, 10
E. Naumova (2010)
Visual analytics for immunologists: Data compression and fractal distributions.Self/nonself, 1 3
R. Kimball, Margy Ross, W. Thornthwaite, Joy Mundy, Bob Becker (2009)
The Data Warehouse Lifecycle Toolkit
H. Seidling, S. Phansalkar, D. Seger, M. Paterno, S. Shaykevich, W. Haefeli, D. Bates (2011)
Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision supportJournal of the American Medical Informatics Association : JAMIA, 18 4
Natsuhiko Kumasaka, Yusuke Nakamura, N. Kamatani (2010)
The Textile Plot: A New Linkage Disequilibrium Display of Multiple-Single Nucleotide Polymorphism Genotype DataPLoS ONE, 5
E. Fortescue, R. Kaushal, C. Landrigan, K. McKenna, M. Clapp, F. Federico, D. Goldmann, D. Bates (2003)
Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients.Pediatrics, 111 4 Pt 1
M. Guzek, O. Zorina, A. Semmler, R. Gonzenbach, M. Huber, G. Kullak-Ublick, M. Weller, S. Russmann (2011)
Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System)Pharmacoepidemiology and Drug Safety, 20
J. Ash, M. Berg, E. Coiera (2004)
Viewpoint Paper: Some Unintended Consequences of Information Technology in Health Care: The Nature of Patient Care Information System-related ErrorsJ. Am. Medical Informatics Assoc., 11
Pamela Smithburger, Sandra Gill, Neal Benedict, B. Falcione, Amy Seybert (2010)
Grading the Severity of Drug-Drug Interactions in the Intensive Care Unit: A Comparison Between Clinician Assessment and Proprietary Database Severity RankingsAnnals of Pharmacotherapy, 44
Pamela Smithburger, M. Buckley, Sharon Bejian, Katie Burenheide, S. Kane-Gill (2011)
A critical evaluation of clinical decision support for the detection of drug–drug interactionsExpert Opinion on Drug Safety, 10
A. Jha, J. Laguette, A. Seger, D. Bates (2008)
Research Paper: Can Surveillance Systems Identify and Avert Adverse Drug Events? A Prospective Evaluation of a Commercial ApplicationJournal of the American Medical Informatics Association : JAMIA, 15 5
Vishal Shah, R. Weber, M. Nahata (2011)
Contradictions in Contraindications for Drug-Drug InteractionsAnnals of Pharmacotherapy, 45
E. Tufte (1985)
The Visual Display of Quantitative InformationTechnometrics, 44
D. Cullen, D. Bates, S. Small, J. Cooper, A. Nemeskal, L. Leape (1995)
The incident reporting system does not detect adverse drug events: a problem for quality improvement.The Joint Commission journal on quality improvement, 21 10
Ervina Resetar, R. Reichley, Laura Noirot, W. Dunagan, T. Bailey (2005)
Customizing a Commercial Rule Base for Detecting Drug-Drug InteractionsAMIA ... Annual Symposium proceedings. AMIA Symposium
S. Phansalkar, H. Sijs, Alisha Tucker, Amrita Desai, D. Bell, J. Teich, Blackford Middleton, D. Bates (2012)
Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health recordsJournal of the American Medical Informatics Association : JAMIA, 20 3
S. Weingart, M. Tóth, D. Sands, M. Aronson, Roger Davis, R. Phillips (2003)
Physicians' decisions to override computerized drug alerts in primary care.Archives of internal medicine, 163 21
Peter Fayers, E. Tufte (1990)
The Visual Display of Quantitative InformationJournal of The Royal Statistical Society Series A-statistics in Society, 153
S. Phansalkar, Amrita Desai, D. Bell, E. Yoshida, John Doole, Melissa Czochanski, Blackford Middleton, D. Bates (2012)
High-priority drug-drug interactions for use in electronic health recordsJournal of the American Medical Informatics Association : JAMIA, 19 5
G. Kuperman, R. Reichley, T. Bailey (2006)
Editorial Comments: Using Commercial Knowledge Bases for Clinical Decision Support: Opportunities, Hurdles, and RecommendationsJournal of the American Medical Informatics Association : JAMIA, 13 4
Objective To develop and evaluate an electronic dashboard of hospital-wide electronic health record medication alerts for an alert fatigue reduction quality improvement project.Methods We used visual analytics software to develop the dashboard. We collaborated with the hospital-wide Clinical Decision Support committee to perform three interventions successively deactivating clinically irrelevant drugdrug interaction (DDI) alert rules. We analyzed the impact of the interventions on care providers’ and pharmacists’ alert and override rates using an interrupted time series framework with piecewise regression.Results We evaluated 2 391 880 medication alerts between January 31, 2011 and January 26, 2014. For pharmacists, the median alert rate prior to the first DDI deactivation was 58.74 alerts/100 orders (IQR 54.9860.48) and 25.11 alerts/100 orders (IQR 23.4526.57) following the three interventions (p<0.001). For providers, baseline median alert rate prior to the first round of DDI deactivation was 19.73 alerts/100 orders (IQR 18.6620.24) and 15.11 alerts/100 orders (IQR 14.4415.49) following the three interventions (p<0.001). In a subgroup analysis, we observed a decrease in pharmacists’ override rates for DDI alerts that were not modified in the system from a median of 93.06 overrides/100 alerts (IQR 91.9694.33) to 85.68 overrides/100 alerts (IQR 84.2987.15, p<0.001). The medication serious safety event rate decreased during the study period, and there were no serious safety events reported in association with the deactivated alert rules.Conclusions An alert dashboard facilitated safe rapid-cycle reductions in alert burden that were temporally associated with lower pharmacist override rates in a subgroup of DDIs not directly affected by the interventions; meanwhile, the pharmacists’ frequency of selecting the ‘cancel’ option increased. We hypothesize that reducing the alert burden enabled pharmacists to devote more attention to clinically relevant alerts.
Journal of the American Medical Informatics Association – Oxford University Press
Published: Mar 15, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.